Short Interest in Celularity Inc. (NASDAQ:CELUW) Declines By 6.7%

Celularity Inc. (NASDAQ:CELUWGet Free Report) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 117,400 shares, a drop of 6.7% from the February 29th total of 125,800 shares. Based on an average daily volume of 47,100 shares, the short-interest ratio is currently 2.5 days.

Celularity Price Performance

Celularity stock opened at $0.05 on Wednesday. Celularity has a 52 week low of $0.00 and a 52 week high of $0.16. The company has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.03.

About Celularity

(Get Free Report)

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.

Further Reading

Receive News & Ratings for Celularity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celularity and related companies with MarketBeat.com's FREE daily email newsletter.